Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
|
|
PharmaCyte Biotech, Inc. (NVLX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/31/2023 |
10-K
| Annual Report for the period ended April 30, 2023 |
| 07/28/2022 |
10-K
| Annual Report for the period ended April 30, 2022 |
| 08/10/2021 |
10-K
| Annual Report for the period ended April 30, 2021 |
| 08/13/2020 |
10-K
| Annual Report for the period ended April 30, 2020 |
| 08/12/2019 |
10-K
| Annual Report for the period ended April 30, 2019 |
| 07/20/2018 |
10-K
| Annual Report for the period ended April 30, 2018 |
| 07/27/2017 |
10-K
| Annual Report for the period ended April 30, 2017 |
| 07/29/2016 |
10-K
| Annual Report for the period ended April 30, 2016 |
| 07/29/2015 |
10-K
| Annual Report for the period ended April 30, 2015 |
| 08/04/2014 |
10-K
| Annual Report for the period ended April 30, 2014 |
| 07/29/2013 |
10-K
| Annual Report for the period ended April 30, 2013 |
| 08/14/2012 |
10-K
| Annual Report for the period ended April 30, 2012 |
| 08/15/2011 |
10-K
| Annual Report for the period ended April 30, 2011 |
| 12/29/2010 |
10-K
| Annual Report for the period ended April 30, 2010 |
| 08/13/2009 |
10-K
| Annual Report for the period ended April 30, 2009 |
|
|